Keiasha Jordan
Family · Birmingham, ALNPI 1427833771
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $811, 4.6 times the $178 reported in 2023.
Across 84 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$228
- Merck$228
- Novartis$226
- AstraZeneca$137
- Pfizer$118
- Irhythm Technologies, Inc.$114
- plus $600 from 13 others
What the payments were for
- Food & beverage$1,651100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $228 |
| Merck | 13 | $228 |
| Novartis | 12 | $226 |
| AstraZeneca | 8 | $137 |
| Pfizer | 6 | $118 |
| Irhythm Technologies, Inc. | 4 | $114 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $90 |
| Alnylam Pharmaceuticals Inc. | 4 | $77 |
| Bayer | 3 | $62 |
| Inari Medical, Inc. | 2 | $60 |
| Scpharmaceuticals Inc. | 3 | $56 |
| Lexicon Pharmaceuticals, Inc. | 2 | $54 |
| Amgen | 3 | $42 |
| Boehringer Ingelheim | 2 | $39 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Ionis Pharmaceuticals, Inc. | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $15 |
| Altathera Pharmaceuticals LLC | 1 | $12 |
How this compares
$1,651 in reported general payments places this provider in the 70th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 17 | $85 |
| ClopidogrelClopidogrel Bisulfate | 12 | $80 |
Paid to pharmacies, not to this prescriber.
Other family in Birmingham
- Kellyn McMahonBirmingham$39K
- Rachel MesserBirmingham$22K
- Juyong JacksonBirmingham$21K
- Abigail McCroryBirmingham$19K
- Danielle BlackardBirmingham$19K
- Leanne PeoplesBirmingham$17K
- Brandie WeidmanBirmingham$13K
- Alison PetersonBirmingham$13K
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.